Unblinded: A Clinical Trial Podcast AI and Clinical Transformation: High-Value or Hype?
Oct 11, 2024
Ibrahim Kamstrup-Akkaoui, Vice President for Clinical Data Operations at Novo Nordisk, shares insights from his journey in IT and clinical data management. He discusses the rapid growth of data in clinical trials and how AI can be harnessed to manage this effectively. Key topics include the transition from legacy systems to robust digital platforms, the importance of patient-centric design, and practical AI applications that enhance efficiency in trial setups. Ibrahim emphasizes starting small with innovative solutions while keeping a visionary outlook for scaling technologies.
AI Snips
Chapters
Transcript
Episode notes
From Fax Machines To EDC
- Ibrahim recalls joining Novo Nordisk in 2007 and encountering fax machines and paper-based processes.
- He contrasts that with discovering EDC and how user feedback improved digital adoption.
Consolidate Systems For Sites And Patients
- Ibrahim explains sites and patients currently juggle dozens of systems across sponsors, creating burden and quality issues.
- He argues simplifying to a platform approach will improve user experience and data quality.
Data Has Become A Strategic Asset
- Data volume grew from millions to roughly two billion data points per year at Novo Nordisk.
- Ibrahim highlights this exponential growth makes data a strategic asset requiring new infrastructure and analytics.